NCT00041262View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Esophageal Cancer

PHASE3UnknownINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

November 30, 2004

Conditions
Esophageal Cancer
Interventions
DRUG

cisplatin

DRUG

epirubicin hydrochloride

DRUG

fluorouracil

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

B15 2TH

RECRUITING

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV